Trending...
- Yet another EU country´s Data Protection Authority makes it official! Google Analytics is out!
- SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Yatsen Holding Limited with Losses of $100,000 to Contact the Firm
- SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Barclays PLC with Losses of $100,000 to Contact the Firm
LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Enochian Biosciences, Inc. ("Enochian" or "the Company") (NASDAQ: ENOB) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors who purchased the Company's securities between January 17, 2018 and June 27, 2022, inclusive (the ''Class Period''), are encouraged to contact the firm before September 26, 2022.
If you are a shareholder who suffered a loss, click here to participate.
More on The Californer
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Enochian co-founder Serhat Gumrukcu was not a licensed physician and did not hold a verifiable college degree of any type. The Company's science and technology, credited to Gumrukcu, were not likely to be legitimate. The Company overstated the commercial viability of its product pipeline. The Company's senior executives were aware of Gumrukcu's history including fraud. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Enochian, investors suffered damages.
More on The Californer
Join the case to recover your losses.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Contacts
The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com
Investors who purchased the Company's securities between January 17, 2018 and June 27, 2022, inclusive (the ''Class Period''), are encouraged to contact the firm before September 26, 2022.
If you are a shareholder who suffered a loss, click here to participate.
More on The Californer
- Dynamic Design Solutions Announces Best Sales Year on Record in Back-to-Back Fiscal Years
- Enersponse and NexRev Partner to Empower Customers With Access to Energy Management Solutions
- PARAMOUNT CONSUMER PRODUCTS AND NICKELODEON ANNOUNCE LAUNCH OF GLOBAL OCEAN CONSERVATION AND SUSTAINABILITY INITIATIVE SPONGEBOB SQUAREPANTS: OPERATION SEA CHANGE
- BookingPal Integrates Airbnb Reviews to Help Property Managers Improve Vacation Rental Rankings
- Sydney Brachytherapy Group is the first private non-melanoma skin cancer clinic in Sydney to offer OncoBeta's Rhenium-SCT
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Enochian co-founder Serhat Gumrukcu was not a licensed physician and did not hold a verifiable college degree of any type. The Company's science and technology, credited to Gumrukcu, were not likely to be legitimate. The Company overstated the commercial viability of its product pipeline. The Company's senior executives were aware of Gumrukcu's history including fraud. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Enochian, investors suffered damages.
More on The Californer
- PermaTherm Announces Panels Delivered Quickly Program
- General Inception Creates First-Ever "Igniter" for New Company Formation
- ASI Hosts 24th Annual iNNOVATIONS Conference and Announces Award Winners
- NuVasive Announces Agenda for Investor Day 2022
- Lionrock Adds Ketamine Assisted Psychotherapy Program to State-of-the-Art Treatment Offerings for Substance Use Disorder
Join the case to recover your losses.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Contacts
The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com
Filed Under: Business
0 Comments
Latest on The Californer
- Water Reclamation Facility in Moorpark informing future drought resilience
- Asian Hall of Fame Announces Induction 2022
- State Gives $130 Million Boost to Projects Essential to Reliabilty of Southern California's Water Supply
- Distroller Donates Neonate Babies to NICU Families for NICU Sibling Support Day on Sept. 29
- California: On the Record with Governor Gavin Newsom: Saving Water & Building a More Resilient Future
- ATEN Technology Renovates the Desktop for the Hybrid Work Challenge with New KVM Switch
- Experienced Intellectual Property Attorney Christopher Franich Joins Snell & Wilmer's SD Office
- Triunfo Water & Sanitation District Board Approves Reducing Sprinkler Irrigation Time
- Edge AI Innovator Femtosense Raises $8 Million Series A Funding
- CHIRLA, IMMIGRANT RIGHTS GROUPS MOBILIZE IN SUPPORT OF BILL TO EXPAND A PATHWAY FOR RESIDENCY FOR MILLIONS OF LONG-TERM RESIDENTS.
- BEAR Technologies Successfully Completes 2022 SOC 2 Type II Audit
- Exterro Launches FTK® Suite 7.6, Introducing Mobile Parsing, Automation Capabilities, And Industry-First Remote Endpoint Triage
- Lassen Therapeutics Commences Dosing in Phase 1 Clinical Study of LASN01, a First-in-Class Interleukin-11 Receptor-Blocking Antibody
- Honda Advances Support of Hispanic Scholarship Fund with $1 Million Donation
- Re-Introducing Gigahurtz, DJ and Producer
- Pureboost, Amazon's #1 Selling Clean Energy Drink, Raises Over $2M+ Within Hours of Launching Community Round to the Public on Wefunder's Community Investment Platform
- Creating a Telegram sticker pack for brand advertising
- Leopard Imaging to Showcase at VISION in Stuttgart with 2D and 3D Depth Cameras Empowered by onsemi
- Shana Tovah! Happy Rosh Hashanah!
- Tigo Energy Surpasses One-Terawatt Hour of Monitored Solar PV Energy in Europe